Overview
Rob Ruijtenbeek practices in 's-hertogenbosch, Netherlands. His top areas of expertise are Renal Cell Carcinoma (RCC), Non-Small Cell Lung Cancer (NSCLC), Melanoma, and Lung Cancer.
His clinical research consists of co-authoring 46 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- FibrosarcomaMr. Ruijtenbeek isExperienced. Learn about Fibrosarcoma.
- Lung CancerMr. Ruijtenbeek isExperienced. Learn about Lung Cancer.
- MelanomaMr. Ruijtenbeek isExperienced. Learn about Melanoma.
- Metastatic Uveal MelanomaMr. Ruijtenbeek isExperienced. Learn about Metastatic Uveal Melanoma.
- Multiple MyelomaMr. Ruijtenbeek isExperienced. Learn about Multiple Myeloma.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Ruijtenbeek isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).